Share this video  

SABCS 2022 | Why is IO unsucessful in non-TNBC?

Naoto T. Ueno, MD, PhD, University of Hawaii, Honolulu, HI, discusses the contribution of the tumor micro-environment (TME) to the failure of immunotherapy in breast cancers outside of triple negative breast cancer (TNBC), including fibrotic changes. This interview took place at the San Antonio Breast Cancer Symposium (SABCS) 2022 in San Antonio, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.